CX-5461 Treatment Leads to Cytosolic DNA-Mediated STING Activation in Ovarian Cancer is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Cancer Institute
Grant: 1R01CA241905-01A1
Targeting RNA Polymerase I Transcription Machinery in Chemoresistant Ovarian Cancer
UVA Cancer Center
Grant: DR01020
UVA Cancer Center
Grant: P30 CA44579
National Institutes of Health
Grant: T32CA009109
NCI NIH HHS
Grant: R01 CA241905
NCI NIH HHS
Grant: P30 CA044579
National Institutes of Health
Grant: 3P30CA044579-19S1
Cancer Center Support Grant
National Institutes of Health
Grant: 5F32CA236462-02
Investigating the role of SPRY2 in regulating drug resistance of GBM tumors and interactions between GBM tumor cells and macrophages
National Institutes of Health
Grant: 5T32CA009109-23
CANCER RESEARCH TRAINING IN MOLECULAR BIOLOGY
FWCI
1.32
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals
Additional file 1 of Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis
Additional file 1 of Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis
Additional file 2 of Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis
Additional file 2 of Knockdown of CENPM activates cGAS-STING pathway to inhibit ovarian cancer by promoting pyroptosis